A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06385509
- Locations
- 🇺🇸
Alliance for Multispecialty Research, Norfolk, Virginia, United States
🇺🇸Clinical Trials Research, Lincoln, California, United States
🇺🇸Long Beach Research Institute, LLC, Long Beach, California, United States
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT05645536
- Locations
- 🇺🇸
Texas Oncology - Central South, Austin, Texas, United States
🇧🇷Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil
🇺🇸Marin Cancer Care, Inc., Greenbrae, California, United States
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT04906395
- Locations
- 🇺🇸
Texas Oncology- Deke Slayton Cancer Center, Webster, Texas, United States
🇧🇷Hospital Araujo Jorge, Goiania, Goias, Brazil
🇺🇸Marin Cancer Care, Inc, Greenbrae, California, United States
BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis
- Conditions
- Scalp Psoriasis
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 699
- Registration Number
- NCT03122353
- Locations
- 🇺🇸
Site 29, Fremont, California, United States
🇺🇸Site 18, Sherman Oaks, California, United States
🇺🇸Site 01, Brandon, Florida, United States
Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
- First Posted Date
- 2015-05-25
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT02452931
- Locations
- 🇺🇸
University of Oklahoma College of Medicine, Tulsa, Oklahoma, United States
🇨🇦McGill University Health Centre, Montreal, Quebec, Canada
🇳🇿The Liggins Institute, University of Auckland, Auckland, New Zealand